Indonesia: Surrogacy Contracts, Agencies and Payments
The short answer
As of 24 October 2026, do not treat an Indonesian clinic or agency contract as a safe way to arrange surrogacy. Indonesian law confines assisted reproduction to fertilisation using the married couple’s own sperm and ovum, with the resulting embryo implanted in the wife from whom the ovum came. The current Ministry of Health regulation expressly prohibits a “uterine lending” service in assisted reproductive technology. The immediate practical conclusion is that a contract cannot make a prohibited clinical service lawful merely by calling it coordination, a family-support programme, consultancy or a package. Contract enforceability, the return of money and any personal liability remain separate questions and must be assessed on the actual wording, parties, payments and conduct.
The rules that control assisted reproduction
Law No. 17 of 2023 on Health, Article 58, states that assisted reproduction may be carried out only by lawfully married couples and that the fertilisation result must use their sperm and ovum and be implanted in the uterus of the wife from whom the ovum originated. Article 58 also requires the service to be performed by medical professionals with expertise and authority and at specified health-service facilities. Article 45(2)–(5) of Minister of Health Regulation No. 2 of 2025 repeats this framework, requires proof of marriage, and expressly prohibits several donor services and “pelayanan pinjam rahim” (a uterine-lending service) when providing assisted reproductive technology. The regulation took effect on 20 February 2025; the Health Law took effect on 8 August 2023. These are rules about the permitted clinical service, not a complete code for every private payment or every act by a non-medical intermediary.
Article 49(8) separately restricts surplus embryos: it prohibits implanting them in another woman’s uterus and, in the stated circumstances, in the wife’s uterus if the embryo’s father has died or the spouses have divorced. This specific rule concerns surplus embryos; it reinforces the clinical limits but does not by itself decide the enforceability of a private contract or a child’s parentage.
Clinic permissions and administrative sanctions
Article 76 provides administrative sanctions for medical professionals, health workers and health facilities that breach the prohibitions in Article 45(4)–(5) or the surplus-embryo rules in Article 49(8)–(9); Articles 77–79 detail written warnings, administrative fines and licence revocation. The sanctions may be applied in stages. The text does not say that these particular sanctions automatically apply to every intended parent, translator, travel provider or ordinary commercial agent. Do not expand a defined health-sector sanction into a universal criminal penalty. Article 45(4) separately restricts sex selection, except where needed to avoid a sex-linked genetic disease; that separate rule is not the focus here.
Can a contract make surrogacy enforceable?
A signed agreement is not automatically enforceable simply because the parties agreed on a price, used a notary, chose a foreign governing law or paid by bank transfer. Under the Indonesian Civil Code (Book III), Article 1320 includes a lawful cause among the requirements for a valid agreement; Articles 1335 and 1337 address agreements based on a prohibited cause and causes prohibited by law or contrary to morality or public order. Applied to a contract whose central purpose is to obtain a uterine-lending service that Indonesian health rules prohibit, those provisions create a serious risk that the agreement or its central obligations will not be enforceable. This is a legal assessment from the statutory texts, not a claim that a particular court has already ruled on every surrogacy contract.
Agency and intermediary agreements
Separate the intermediary’s actual services from the prohibited objective. A genuine contract for independent translation, hotel accommodation, ordinary travel booking or legal advice is not automatically the same as a contract to arrange a surrogate pregnancy. Its risk depends on what was promised, how the service was delivered, whether it is genuinely separable, and whether it is being used to disguise the prohibited arrangement. By contrast, a fee expressly paid to recruit a gestational carrier, coordinate embryo transfer into another woman, arrange the pregnancy or guarantee delivery of a child is closely tied to the prohibited clinical service and is highly risky. A company registration, a polished website, a foreign address or the word “consulting” does not establish legal permission.
Payments, milestones and refunds
Do not assume that a payment schedule, escrow label, “non-refundable” clause or invoice makes the underlying transaction lawful. A deposit, agency commission, carrier compensation, clinic charge, travel cost and translation fee should be itemised separately, with the recipient, purpose, deliverable, due date and refund trigger stated for each. That accounting helps identify genuinely independent services, but it does not cure a prohibited purpose. If the main bargain is legally unenforceable, the route to recovering money may also be uncertain; the Civil Code provisions cited here do not guarantee automatic repayment or a particular damages award. Avoid paying into an individual’s account or a third-party wallet without a documented basis, and do not accept a request to relabel a surrogacy payment as a medical, gift or consulting fee.
Practical risk matrix
| Contract/service type | Legal signal | Practical takeaway |
|---|---|---|
| Clinic or fertility provider | Restricted to the statutory assisted-reproduction model; uterine-lending services are expressly prohibited. | Verify designation/licence and the actual procedure in writing; do not rely on a sales promise. |
| Surrogacy agency package | Directly arranging a carrier or transfer into another woman is closely tied to the prohibited service. | High contract and refund risk; pause before paying and obtain independent Indonesian advice. |
| Independent translation or travel | May be a separate lawful service if real, documented and not a disguised surrogacy fee. | Separate the deliverable, provider, invoice and price; keep proof of performance. |
| Carrier / transfer payment | High risk where the payment is for the pregnancy, embryo transfer or promised handover. | A receipt proves payment only; it does not validate the purpose or guarantee recovery. |
| Escrow, refund or foreign-law clause | May affect procedure, but does not by itself override mandatory Indonesian health rules. | Check enforceability, separability, forum and practical recovery before relying on the clause. |
Clauses and documents to check before signing
Before signing, request the full contract and every annex; identify each legal entity and the person receiving money; obtain the actual facility name, address and licence/designation details; and ask which exact service each fee purchases. Check whether the agreement promises a carrier, embryo transfer into another woman, pregnancy, birth, handover of a child or a guaranteed parentage document. Look for vague “success fees”, unilateral deductions, non-refundable deposits, broad powers of attorney, confidentiality clauses that prevent lawful reporting, and clauses requiring false descriptions of payments. Ask for a written explanation of cancellation, failed-cycle costs, medical complications, replacement-carrier proposals, dispute venue and refund calculation. These are risk-screening questions, not a checklist that can legalise a prohibited arrangement.
If you have already signed or paid
If you have already signed or paid, preserve the signed version and all annexes, invoices, bank records, chat messages, advertisements, emails, receipts and statements about licences or refunds. Make a dated chronology of what was promised, what was performed, and who received each payment. Do not destroy records, backdate documents or agree to a false invoice description. Consider a written request for an itemised account, the contractual basis for each deduction and a proposed refund timetable, while reserving your rights. Before threatening litigation or stopping a payment, ask Indonesian counsel to assess the contract’s purpose, any separable lawful services, the evidence of misrepresentation, the dispute clause and the practical forum for recovery. If coercion, exploitation or immediate danger is involved, seek urgent local legal or protective assistance.
If you suspect that a medical professional, health worker or health facility is breaching these specific reproductive-health rules, Articles 80–81 provide a separate administrative reporting route. A report may arise from a complaint or from monitoring and evaluation. A complaint must be in writing, must not be intended to resolve a compensation claim, and must not concern a matter already reported or examined. It must state the reporter’s full name, full address and contact telephone number or email address; the reported party’s name and full address; the suspected conduct and its date; a chronology or supporting facts, data or indications; and the names of witnesses and their involvement. Reports are submitted to the Minister of Health, governor, regent (bupati), mayor (wali kota) or a designated official. Under Article 81, the receiving authority must protect the reporter’s identity, except for law-enforcement purposes. This route is separate from a refund request or civil claim; ask Indonesian counsel to confirm the appropriate filing channel and assess any recovery claim separately.
What this conclusion does not decide
This article does not determine the legal parentage of a child, birth registration, citizenship, passport eligibility, exit permission or recognition in another country. A private contract or agency promise does not itself establish any of those outcomes. Those questions require separate analysis of the applicable family, civil-registration, nationality and immigration rules and the facts of the birth. Nor does the health regulation cited here establish that every client or non-medical intermediary commits a crime merely by signing or paying. The cited regulation specifies administrative sanctions for defined health-sector actors and breaches. Other liability may depend on separate conduct, such as fraud, coercion, exploitation or other independently unlawful acts; no conclusion on those offences should be drawn without checking the relevant law and facts.
Safer next steps
Before committing funds, obtain advice from an Indonesian lawyer who is independent of the clinic and agency. Give counsel the proposed contract, fee schedule, marketing claims, facility details, payment instructions and any foreign-law or arbitration clause. Ask for written answers to five points: (1) which exact service is prohibited or permitted under Articles 58 and 45; (2) whether the proposed clinic is properly designated; (3) which obligations, if any, are genuinely separable; (4) what legal basis and evidence support a refund if the programme is not performed; and (5) which court, arbitration body or authority could realistically hear a dispute. Do not sign or pay on the assumption that a notary, a company licence or a refund promise resolves the substantive prohibition.
Scope and source limits
This guide reflects Law No. 17 of 2023, Minister of Health Regulation No. 2 of 2025 and Book III of the Indonesian Civil Code as of 24 October 2026. The Civil Code text cited is a reproduction, not an official consolidated edition, and no controlling reported judgment on the exact refund and agency-contract questions is known as of that date. The statutory restriction on uterine-lending services is therefore clear, while the civil enforceability of such contracts remains uncertain. The article is limited to contracts, intermediaries and payments connected with surrogacy services in Indonesia. If the clinic, transfer, payment, agency or intended parents are located in different countries, each jurisdiction and any conflict-of-laws question requires separate review.
Primary legal texts and source notes
- S1. Law of the Republic of Indonesia Number 17 of 2023 on Health — Official Ministry of Health JDIH page; English text, including Article 58.
- S2. Peraturan Menteri Kesehatan Republik Indonesia Nomor 2 Tahun 2025 — Official Indonesian regulation text; Articles 45–49 and 76–81.
- S3. Kitab Undang-Undang Hukum Perdata, Buku Ketiga — Reproduced text of Book III, including Articles 1320, 1335, 1337–1338; not an official consolidated edition.
